Aicaigou LogoB2B Wiki

Human Immunodeficiency Virus (HIV)

Updated: 2026-09-20

Overview

Human Immunodeficiency Virus (HIV) is the causative agent of AIDS, first identified in the early 1980s. It belongs to the Lentivirus genus and primarily infects CD4+ T cells, macrophages, and dendritic cells. HIV replicates by reverse transcribing its RNA into DNA, which integrates into the host genome. Globally, approximately 38 million people live with HIV, with sub-Saharan Africa being the most affected region. The virus has two main types: HIV-1 (more prevalent and virulent) and HIV-2 (less transmissible). Early diagnosis and ART can reduce viral loads to undetectable levels, preventing transmission and progression to AIDS.

Key Features

HIV's high genetic variability stems from error-prone reverse transcriptase enzyme, enabling rapid mutation and evasion of immune responses. The viral envelope glycoproteins (gp120 and gp41) facilitate entry into host cells by binding to CD4 and chemokine receptors (CCR5 or CXCR4). Latency is another critical feature—HIV can remain dormant in reservoirs (e.g., memory T cells) for years, complicating eradication. Current research focuses on 'shock and kill' strategies to reactivate and eliminate these reservoirs.

Application Areas

In healthcare, HIV testing is essential for prevention and treatment. Rapid diagnostic tests (RDTs) and nucleic acid tests (NATs) are widely used. Antiretroviral drugs target various stages of the viral lifecycle, including entry inhibitors, reverse transcriptase inhibitors, integrase inhibitors, and protease inhibitors. Public health initiatives emphasize harm reduction (e.g., needle exchanges), mother-to-child transmission prevention, and PrEP for high-risk groups. Research applications include vaccine development and gene editing (e.g., CRISPR) to excise viral DNA.

Precautions

Standard precautions in healthcare involve using gloves, gowns, and proper disposal of sharps to prevent occupational exposure. Post-exposure prophylaxis (PEP) must be initiated within 72 hours of potential exposure. Community education focuses on condom use, voluntary medical male circumcision (VMMC), and avoiding shared needles. Laboratory personnel handling HIV samples must follow biosafety level 2 (BSL-2) protocols to mitigate aerosol risks.

B2B Procurement Guide

Procuring HIV-related products requires compliance with international standards (e.g., WHO, FDA, or CE Mark). Diagnostic kits should have ≥99% sensitivity/specificity. For antiretrovirals, verify generic equivalency through the FDA’s Orange Book or WHO prequalification. Bulk purchasers (e.g., governments, NGOs) should negotiate tiered pricing with manufacturers. Cold chain logistics are critical for certain reagents. Consider long-term supplier reliability and local regulatory approvals to avoid stockouts.

Related Manufacturers